Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19Derek C. Angus, Balasubramanian Venkatesh, Lindsay R. Berry et al.|JAMA|2020Cited by 884
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trialYaseen M. Arabi, Anthony Gordon, Lennie Derde et al.|Intensive Care Medicine|2021Cited by 100
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trialLennie Derde, Ville Pettilä, Anthony Gordon et al.|Thorax|2025Cited by 12
Continuation of therapeutic dose heparin for critically ill patients with COVID-19Charlotte Bradbury, Edward Litton, Patrick R. Lawler et al.|Intensive Care Medicine|2023Cited by 6